Chimeric Therapeutics (ASX:CHM) Other Current Payables: A$0.00 Mil (As of Dec. 2025)


What is Chimeric Therapeutics Other Current Payables?

Chimeric Therapeutics ASX:CHM +1.47% Other Current Payables is A$0.00 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Chimeric Therapeutics's Other Current Payables for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Chimeric Therapeutics's quarterly Other Current Payables increased from Dec. 2024 (A$0.00 Mil) to Jun. 2025 (A$4.31 Mil) but then declined from Jun. 2025 (A$4.31 Mil) to Dec. 2025 (A$0.00 Mil).

Chimeric Therapeutics's annual Other Current Payables declined from Jun. 2023 (A$3.41 Mil) to Jun. 2024 (A$3.00 Mil) but then increased from Jun. 2024 (A$3.00 Mil) to Jun. 2025 (A$4.31 Mil).

Chimeric Therapeutics Other Current Payables Related Terms

Chimeric Therapeutics Other Current Payables Historical Data

* Premium members only.

The historical data trend for Chimeric Therapeutics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chimeric Therapeutics Other Current Payables Chart

Chimeric Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Payables
1.00 1.67 3.41 3.00 4.31

Chimeric Therapeutics Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 3.00 0.00 4.31 0.00

Chimeric Therapeutics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of A$0.00 Mil mean?
Chimeric Therapeutics (ASX:CHM) has a Other Current Payables of A$0.00 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Chimeric Therapeutics and its competitors.
Is Chimeric Therapeutics' Other Current Payables too high?
Chimeric Therapeutics' current Other Current Payables is A$0.00 Mil.
How does Chimeric Therapeutics' Other Current Payables compare to VRTX and REGN?
Chimeric Therapeutics' Other Current Payables of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Chimeric Therapeutics and its competitors. Chimeric Therapeutics's current Other Current Payables is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chimeric Therapeutics stock overvalued right now?
Chimeric Therapeutics (ASX:CHM) has a current Other Current Payables of A$0.00 Mil. The current Other Current Payables is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Chimeric Therapeutics (ASX:CHM), the current Other Current Payables is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chimeric Therapeutics Business Description

Address 62 Lygon Street, Level 3, Carlton, Melbourne, VIC, AUS, 3053
Chimeric Therapeutics Ltd is an Australian clinical-stage cell therapy company focused on developing and commercialising a range of cell therapies in oncology. The group's products under development include T Cell Derived Autologous Therapies and Natural Killer (NK) Cell Derived Allogenic Therapies. T Cell Derived Autologous therapy works by engineering the T cells with the exact coordinates to attack and kill cancer. NK Cell Derived Allogenic Therapies from healthy donors can be manufactured on a large scale and, once administered, kill cancer. Its pipeline products include CDH17, CLTX, and CORE NK. The group has one reportable segment, being the research, development, and commercialisation of health technologies.